Literature DB >> 20224273

Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.

Hideki Fujii1, Keiji Kono, Kentaro Nakai, Shunsuke Goto, Hirotaka Komaba, Yasuhiro Hamada, Masami Shinohara, Riko Kitazawa, Sohei Kitazawa, Masafumi Fukagawa.   

Abstract

BACKGROUND: The role of nitric oxide (NO) is controversial in diabetes nephropathy progression and the mechanisms remain unknown, especially in non-obese type 2 diabetes. To examine mechanisms of nephropathy progression in non-obese type 2 diabetes, we used spontaneously diabetic Torii (SDT) rats, a newly established model of non-obese type 2 diabetes.
METHODS: Fourteen male Sprague-Dawley rats were used as a control (20 weeks, n = 6; 30 weeks, n = 8), and 20-week-old male SDT rats were divided into 2 groups: diabetic (DM, n = 8) and DM + insulin (n = 8) groups. Twenty- and 36-week-old rats were sacrificed, and blood, urine, and histomorphometric analyses, mRNA expression analysis of endothelial NO synthase (eNOS) and NADPH oxidase, and blood pressure measurement were performed.
RESULTS: At 36 weeks, NO metabolites, and 8-hydroxydeoxyguanosine (8-OHdG) were significantly higher in the diabetic group than in the other 2 groups. Further renal studies showed increased glomerular volume and mesangial area, and intensified eNOS, 8-OHdG, and nitrotyrosine immunostaining in the diabetic group. Oxidative and nitrosative stress were positively associated with increased glomerular volume and mesangial area, which were mostly recovered by insulin therapy.
CONCLUSIONS: NO and oxidative stress increased in SDT rats, suggesting that these play key roles in nephropathy progression in non-obese type 2 diabetes. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224273     DOI: 10.1159/000297290

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  13 in total

1.  Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.

Authors:  Hideki Fujii; Yuriko Yonekura; Yusuke Yamashita; Keiji Kono; Kentaro Nakai; Shunsuke Goto; Mikio Sugano; Sumie Goto; Ayako Fujieda; Yoshiharu Ito; Shinichi Nishi
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.

Authors:  Jun Hao; Shuxia Liu; Song Zhao; Qingjuan Liu; Xin Lv; Huan Chen; Yunyi Niu; Huijun Duan
Journal:  Histochem Cell Biol       Date:  2011-01-15       Impact factor: 4.304

3.  Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Authors:  Adam Whaley-Connell; Javad Habibi; Zachary Panfili; Melvin R Hayden; Sarika Bagree; Ravi Nistala; Safwan Hyder; Bennett Krueger; Vincent Demarco; Lakshmi Pulakat; Carlos M Ferrario; Alan Parrish; James R Sowers
Journal:  Am J Nephrol       Date:  2011-06-29       Impact factor: 3.754

4.  Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats.

Authors:  Javad Habibi; Melvin R Hayden; James R Sowers; Lakshmi Pulakat; Roger D Tilmon; Camila Manrique; Guido Lastra; Vincent G Demarco; Adam Whaley-Connell
Journal:  Endocrinology       Date:  2010-12-22       Impact factor: 4.736

5.  Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.

Authors:  Adam Whaley-Connell; Javad Habibi; Ravi Nistala; Melvin R Hayden; Lakshmi Pulakat; Catherine Sinak; Bonnie Locher; Carlos M Ferrario; James R Sowers
Journal:  Regul Pept       Date:  2012-03-29

6.  Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.

Authors:  Zhibo Gai; Ting Gui; Christian Hiller; Gerd A Kullak-Ublick
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

7.  Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin.

Authors:  Junghyun Kim; Eunjin Shon; Chan-Sik Kim; Jin Sook Kim
Journal:  Exp Diabetes Res       Date:  2012-09-27

8.  Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase.

Authors:  Chih-Chun Chang; Chieh-Yu Chang; Yang-Tzu Wu; Jiung-Pang Huang; Tzung-Hai Yen; Li-Man Hung
Journal:  J Biomed Sci       Date:  2011-06-23       Impact factor: 8.410

9.  The spontaneously diabetic torii rat: an animal model of nonobese type 2 diabetes with severe diabetic complications.

Authors:  Tomohiko Sasase; Takeshi Ohta; Taku Masuyama; Norihide Yokoi; Akihiro Kakehashi; Masami Shinohara
Journal:  J Diabetes Res       Date:  2013-02-26       Impact factor: 4.011

10.  Inflammation and oxidative stress in obesity-related glomerulopathy.

Authors:  Jinhua Tang; Haidong Yan; Shougang Zhuang
Journal:  Int J Nephrol       Date:  2012-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.